Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment
ClinicalTrials.gov study NCT05957510. IPD Sharing: NO. Countries: 1. Publications: 1.
Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin
ClinicalTrials.gov study NCT00552149. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Efficacy of Topical Timolol Combined With Cryotherapy in EGFR Inhibitors-induced Paronychia - a Double-blinded, Intrapatient Left-to-right Controlled Study
ClinicalTrials.gov study NCT05165082. IPD Sharing: NO. Countries: 1. Publications: 2.
The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib
ClinicalTrials.gov study NCT01608841. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients
ClinicalTrials.gov study NCT04184921. IPD Sharing: NO. Countries: 1. Publications: 5.
DAHANCA 19: The Importance of the EGFr-inhibitor Zalutumumab for the Outcome After Curative Radiotherapy for HNSCC
ClinicalTrials.gov study NCT00496652. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) Expressions
ClinicalTrials.gov study NCT00637091. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR
ClinicalTrials.gov study NCT01556191. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Real World Study in Locally Advanced or Metastatic NSCLC Patients, Progressed From First-line EGFR-TKI Therapy
ClinicalTrials.gov study NCT04207775. IPD Sharing: NO. Countries: 1. Publications: 1.
Pemetrexed vs Pemetrexed Plus Cisplatin in EGFR-mutant NSCLC Patients After First Line EGFR-TKIs Failure
ClinicalTrials.gov study NCT02725918. IPD Sharing: NO. Countries: 1. Publications: 4.
A Phase I Study of Safety and Pharmacokinetics of Volitinib in Combination With Gefitinib in EGFR(+) NSCLC
ClinicalTrials.gov study NCT02374645. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease.
ClinicalTrials.gov study NCT03994393. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib
ClinicalTrials.gov study NCT00815971. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer
ClinicalTrials.gov study NCT01580735. IPD Sharing: Not stated. Countries: 1. Publications: 1.
High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations
ClinicalTrials.gov study NCT00372515. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Furmonertinib Combined With Anlotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC
ClinicalTrials.gov study NCT04895930. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation
ClinicalTrials.gov study NCT03486496. IPD Sharing: YES. Countries: 1. Publications: 1.
Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or
ClinicalTrials.gov study NCT03065387. IPD Sharing: Not stated. Countries: 1. Publications: 1.
First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Gr
ClinicalTrials.gov study NCT05099172. IPD Sharing: NO. Countries: 15. Publications: 1.
Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer
ClinicalTrials.gov study NCT02352571. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.